Infectious Diseases – News and Features
News
GE Healthcare Grants License for Biomagnetic Isolation of Nucleic Acids to NorDiag ASA
The license grants NorDiag ASA certain rights with respect to the isolation and purification of nucleic acids using GE Healthcare's magnetic separation technology.
News
Diosynth Biotechnology Announces Agreement with VGX Pharmaceuticals
Diosynth has signed an agreement with VGX for process development activities and cGMP production of clinical trial material for their biological therapeutic drug candidate.
News
Nucleonics Receives FDA Clearance to Begin Phase 1 Trial of eiRNA Therapy
The Company to start Phase 1 human safety study of its investigational eiRNA therapy for the treatment of chronic hepatitis B infection.
News
CLC Bio Joins $2.5M Research Project to Develop Software to Study RNA-Based Diseases
CLC Bio will work with two Danish research groups to design bioinformatic algorithms to study the molecular structure and evolution of certain viruses.
News
Proteome Systems Sells Rights to Technology Products to Shimadzu
Under the deal, Proteome Systems will receive cash and the provision of Shimadzu’s latest mass spectrometer and protein separation technology.
News
German Genomics Research Project to Analyze DNA Samples Using Affymetrix Technology
National Genome Research Network has purchased Affymetrix’s Genome-Wide Human SNP Array 5.0 to genotype 17,000 individuals in a study of 25 diseases.
News
Experiments Begin at Australian Synchrotron
Scientists in Australia have begun experiments at the Australian Synchrotron located in Melbourne this week in preparation for the facility’s opening in July.
News
Study of RNA Silencing to Treat Life-Threatening Diseases
Sainsbury Laboratory scientists will lead an €11.8-million research consortium that will study the potential uses for RNA interference in treating disease.
News
Cepheid's Xpert™ MRSA PCR-Based Drug Resistant Test Receives FDA Clearance
The US FDA has cleared a Cepheid’s PCR test which is designed to detect nosocomial and antibiotic-resistant strain of Staphylococcus in over one hour.
News
New Study Zeroes in on the Genetic Roots of Alzheimer's
Oklahoma Medical Research Foundation researchers have discovered a molecule that may lead to drug treatment for Alzheimer's disease.
Advertisement